BOSTON SCIENTIFIC CORP — Director's Dealing 2020

Dec 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-12-01

Reporting Person: Mirviss Jeffrey B. (EVP&Pres, Periph Intervent)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-01	Common Stock	M	46584.0000	$7.1600	Acquired	178067.0000	Direct
2020-12-01	Common Stock	S	46584.0000	$33.5331	Disposed	131483.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-01	Stock Option (Right to Buy)	$7.1600	M	46584.0000	Disposed	2021-02-28	Common Stock (46584.0000)	Direct

Footnotes

F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Includes 25,000 shares from grantor retained annuity trust that terminated on November 11, 2020.

F3: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.40 to $33.745, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Grant to reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.